Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Postthrombotic syndrome in children.

Marilyn J Manco-Johnson1

  • 1Mountain States Regional Hemophilia and Thrombosis Center, Department of Pediatrics, University of Colorado Health Sciences Center and The Children's Hospital, Denver, Colorado 80045-0507, USA. marilyn.manco-johnson@uchsc.edu

Acta Haematologica
|March 22, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of Patient-Reported Outcomes with Hemophilia A Inhibitor Status and Treatment Product Type.

Journal of clinical medicine·2026
Same author

Risk factors for joint bleeding in severe hemophilia A and B: analysis of the Community Counts longitudinal surveillance cohort.

Blood vessels, thrombosis & hemostasis·2025
Same author

A Naturally Occurring Gain-of-Function Mutation in Factor VIII.

The New England journal of medicine·2025
Same author

Joint reaction and simulated muscle forces during squatting and walking in persons with hemophilia.

Clinical biomechanics (Bristol, Avon)·2024
Same author

Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years.

Journal of thrombosis and haemostasis : JTH·2024
Same author

Anticoagulation in Pediatric Patients.

Techniques in vascular and interventional radiology·2024

Postthrombotic syndrome (PTS) affects children after deep vein thrombosis (DVT), causing limb pain and swelling. Early recognition and management of risk factors are crucial for better outcomes in pediatric PTS.

Area of Science:

  • Vascular Medicine
  • Pediatric Thrombosis
  • Clinical Sequelae

Background:

  • Postthrombotic syndrome (PTS) is a complication following deep vein thrombosis (DVT).
  • While DVT in children is increasingly recognized, the long-term limb consequences are significant.
  • PTS involves venous obstruction and/or reflux, leading to symptoms like pain, swelling, and ulcers.

Purpose of the Study:

  • To describe the clinical condition of PTS in children.
  • To identify risk factors associated with PTS development in pediatric patients.
  • To discuss potential strategies for PTS prevention and management.

Main Methods:

  • Utilized an evaluation tool adapted from an international adult scale for PTS diagnosis.
  • Identified risk factors including Factor VIII activity, D-dimer levels, clot characteristics, and observation duration.

Related Experiment Videos

  • Reviewed existing literature on pediatric venous thromboembolism and its sequelae.

    • Main Results:

    • PTS presents with a spectrum of symptoms, from limb swelling to stasis ulcers.
    • Key risk factors identified include elevated Factor VIII, D-dimer, clot occlusiveness/persistence, number of involved venous segments, and duration of follow-up.
    • A validated diagnostic tool for pediatric PTS is available.

    Conclusions:

    • Postthrombotic syndrome is a recognized complication in children following DVT.
    • Specific risk factors can predict PTS development in pediatric populations.
    • Further research is needed to establish optimal prevention and treatment strategies, but early interventions like antithrombotic therapy and lifestyle modifications may improve outcomes.